CaMKII Inhibition Attenuates Distinct Gain-of-Function Effects Produced by Mutant Nav1.6 Channels and Reduces...

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Aberrant Nav1.6 channel activity is linked to epilepsy.
• Gain-of-function mutations in the SCN8A gene contribute to epilepsy development.
• Post-translational modifications, including CaMKII phosphorylation, can regulate Nav1.6 channel function.

Purpose of the Study:

• Investigate how CaMKII modulates disease-linked Nav1.6 mutants.
• Characterize the functional effects of the epilepsy-associated R639C Nav1.6 mutation.
• Assess the therapeutic potential of CaMKII inhibition for epilepsy.

Main Methods:

• Whole-cell voltage clamp recordings in ND7/23 cells.
• Electrophysiological characterization of wild-type (WT) and mutant Nav1.6 channels.
• Computational simulations of neuronal excitability.

Main Results:

• CaMKII inhibition affected the R850Q mutant similarly to WT Nav1.6.
• The R639C mutation demonstrated gain-of-function effects, including increased sodium currents and hyperpolarized activation.
• R639C mutation disrupted CaMKII phosphorylation at T642, altering channel response to CaMKII inhibition.
• Modeled neurons with R639C or R850Q mutations exhibited hyperexcitability, which was reduced by simulated CaMKII inhibition.

Conclusions:

• CaMKII plays a differential role in modulating WT, R850Q, and R639C Nav1.6 channels.
• The R639C mutation's unique response to CaMKII highlights the heterogeneity of SCN8A-linked epilepsy.
• Acute CaMKII inhibition shows promise for mitigating Nav1.6 gain-of-function channelopathies.